Loading insider details...
Beta
Latest Form 4 (Mar 3, 2026): Grant/Award of 54,876 PDSB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 3, 2026 | PDS Biotechnology Corp (PDSB) | Grant/Award | 54,876 | n/a |
| Jul 15, 2025 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/Award | 11,066 | n/a |
| Jun 11, 2025 | PDS Biotechnology Corp (PDSB) | Grant/Award | 22,700 | n/a |
| Mar 3, 2025 | PDS Biotechnology Corp (PDSB) | Purchase | 15,060 | $25.0K |
| Jul 19, 2024 | ZyVersa Therapeutics, Inc. (ZVSA) | Grant/Award | 132 | n/a |
| Jun 25, 2024 | PDS Biotechnology Corp (PDSB) | Grant/Award | 9,000 | n/a |
| Jun 6, 2024 | Axogen, Inc. (AXGN) | Exercise/Conversion | 11,904 | n/a |
| Mar 8, 2024 | Axogen, Inc. (AXGN) | Sale | 25,000 | $225.0K |
| Sep 7, 2023 | Axogen, Inc. (AXGN) | Grant/Award | 20,436 | n/a |
| Jul 17, 2023 | PDS Biotechnology Corp (PDSB) | Grant/Award | 9,000 | n/a |